GregoryAramDanielsMD

Clinical Trials

• Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma Start of enrollment: 2006 Feb 01

  Completed

  Phase 1

• A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma Start of enrollment: 2007 Jun 01

  Unknown status

  Phase 2

• PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01

  Completed

• Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer Start of enrollment: 2012 Apr 01

  Completed

  Phase 1

• HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Start of enrollment: 2012 Aug 01

  Terminated

  Phase 4

• Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. Start of enrollment: 2013 Jul 01

  Terminated

  Phase 1, Phase 2

• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14

  Completed

  Phase 2

• Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients Start of enrollment: 2012 Apr 01

  Unknown status

  Phase 1

• Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors Start of enrollment: 2020 Oct 07

  Recruiting

  Phase 1

• High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma Start of enrollment: 2019 May 23

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact, Sponsor-Investigator

• Join now to see all